Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.

Miyagi, Hiroko; Kwenda, Elizabeth; Ramnaraign, Brian H; Chatzkel, Jonathan A; Brisbane, Wayne G; O'Malley, Padraic; Crispen, Paul L

Miyagi, Hiroko; Kwenda, Elizabeth; Ramnaraign, Brian H; Chatzkel, Jonathan A; Brisbane, Wayne G; O'Malley, Padraic; Crispen, Paul L.

Afiliação

Miyagi H; Department of Urology, University of Florida, Gainesville, FL 32611, USA.
Kwenda E; Department of Urology, University of Florida, Gainesville, FL 32611, USA.
Ramnaraign BH; Department of Medicine, University of Florida, Gainesville, FL 32611, USA.
Chatzkel JA; Department of Medicine, University of Florida, Gainesville, FL 32611, USA.
Brisbane WG; Department of Urology, University of Florida, Gainesville, FL 32611, USA.
O'Malley P; Department of Urology, University of Florida, Gainesville, FL 32611, USA.
Crispen PL; Department of Urology, University of Florida, Gainesville, FL 32611, USA.

Cancers (Basel) ; 15(1)2022 Dec 28.

Article em En | MEDLINE | ID: mdl-36612164

Palavras-chave

complete response; neoadjuvant chemotherapy; radical cystectomy; urothelial carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google